Breastcancer.org Podcast

338 Avsnitt

1. Mental Health Benefits of Pets

   Publicerades: 2022-08-19
2. How Therapy Can Help People Affected by Breast Cancer

   Publicerades: 2022-08-05
3. Fezolinetant: A Non-Hormonal Treatment for Hot Flashes

   Publicerades: 2022-07-22
4. Enhertu for HER2-Low Breast Cancer

   Publicerades: 2022-07-08
5. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Publicerades: 2022-06-24
6. Genetic and Genomic Tests: What’s the Difference?

   Publicerades: 2022-06-02
7. Just Ask: Increasing Diversity in Clinical Trials

   Publicerades: 2022-05-27
8. Dating and Breast Cancer

   Publicerades: 2022-04-29
9. Adolescent and Young Adult Breast Cancer

   Publicerades: 2022-03-28
10. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

    Publicerades: 2021-12-21
11. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

    Publicerades: 2021-12-13
12. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

    Publicerades: 2021-12-11
13. Alcohol and Breast Cancer Risk

    Publicerades: 2021-11-05
14. Breast Cancer Research at ESMO 2021

    Publicerades: 2021-10-21
15. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Publicerades: 2021-10-01
16. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Publicerades: 2021-09-24
17. The Importance of Diversity in Breast Cancer Clinical Trials

    Publicerades: 2021-09-15
18. Tattoo Ink Showing Up on Mammograms

    Publicerades: 2021-08-20
19. Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage

    Publicerades: 2021-07-27
20. Reconstruction Options After Lumpectomy

    Publicerades: 2021-07-16